improve expression characteristics and manufacturing properties of genetic medicine assets. Houdini Bio works with partners developing next-generation genetic therapies who seek to enhance therapeutic index and production output. Its core offering centers on a DNA redesign engine that enables systematic exploration of sequence space to generate constructs with improved functional profiles. The company positions its capabilities for use in biopharmaceutical research and development workflows for genetic medicines. Houdini Bio concentrates on supporting organizations working on advanced genetic therapeutics that require improved construct design and manufacturability.